IndraLab

Statements


PTEN inhibits phosphorylated MTOR. 6 / 6
| 6

reach
"In human hepatocellular carcinoma, PTEN loss and overexpression of p-AKT and p-mTOR were correlated with TNM stage, vascular invasion, intrahepatic metastasis, tumor grade, and Ki-67 high expression, and PTEN loss was associated with p-AKT, p-mTOR, and MMP-9 overexpression [XREF_BIBR]."

reach
"Western blot assay further demonstrated that Scutellarin administration significantly enhanced the expression of PTEN but downregulated p-AKT and p-mTOR in dissected tumor tissues."

reach
"In HCC, PTEN loss and overexpression of p-AKT and p-mTOR were associated with tumor grade, intrahepatic metastasis, vascular invasion, TNM stage and high Ki-67 labeling index (P < 0.05)."

reach
"We found that MTE treatment increased PTEN level and decreased p-AKT and AKT and p-mTOR and m-TOR."

reach
"The overexpression of miR-486 inhibited the expression of PTEN both at the mRNA and protein levels and thus increased the levels of AKT, phosphorylated AKT, mTOR and phosphorylated mTOR."

reach
"Western blotting indicated harmine significantly promoted E-cadherin and PTEN expression, while suppressed N-cadherin, vimentin, PI3K, p-mTOR, and AKT levels."